Because isocitrate dehydrogenase (IDH) glioma mutants showed a better prognosis compared to IDH-wildtype glioma patients, in the astrocytic brain tumour subgroup we also analyzed Nogo-A, MAG, and OMgp levels depending on the IDH1 gene mutation. The gene discussed is OMG; the disease is central nervous system cancer.